Instructor Notes — Chapter 12

What this chapter is doing

Chapter 12 is the pivot of Part 2. Chapters 8 through 11 establish that GLP-1 receptor agonists work. Chapter 12 establishes that "works" is not the same as "available," and that the gap between those two words is where most of the actual human consequence of this drug class lives.

It is also the chapter where the book's second discipline is introduced: fair presentation of contested positions. Chapters 1 through 11 teach students to distinguish good evidence from bad. Chapter 12 asks them to handle questions where evidence does not decide, and to notice the difference. Students who are good at the first skill are often bad at the second — they mistake having a strong opinion for having evaluated something.

Time. Six to eight hours of student work including the case studies. In a taught course, budget two sessions: one for §12.1–§12.7 (money, supply, and law) and one for §12.8–§12.11 (equity, framing, and harm). Do not try to teach §12.9 in the back half of a session about pricing; it needs its own runway.


The three things students most reliably get wrong

1. They collapse the four prices. Almost every student arrives believing there is one price and that someone is being greedy about it. The four-price ladder in §12.1 is the highest-yield fifteen minutes in the chapter. A good diagnostic: ask them to explain why an insured patient can pay less than an uninsured one for the same product from the same pharmacy, and watch how many reach for "insurance negotiates a discount" without being able to say who receives it.

2. They cannot state a position they dislike. §12.9 exercise 12.31 is the assessment for this and it is worth grading strictly. The characteristic failure is a "behavior" paragraph written as a straw man and a "disease" paragraph written as the author's own view. The tell is adjectives.

3. They read "no evidence of harm" as "evidence of no harm." §12.10 is built around this and the quiz revisits it at item 22. Trials excluded people with active eating disorders, so the absence of a signal is an artifact of the exclusion criterion. Students find this obvious when stated and reproduce the error within a week under any other topic.


Handling the two sensitive sections

§12.9 (what obesity is). The book takes no position and you should not either while the section is being worked. State that explicitly at the start; students will otherwise spend the session trying to detect your view instead of constructing arguments. If your group is homogeneous in its priors — and most are — assign positions rather than letting students choose, and require the position paragraphs before any personal view is voiced.

The load-bearing move is the logical point at the end: a drug that works on a system is not evidence that the system caused the condition. This is neutral between all four positions and it is the thing students should still have in ten years. Reinforce it with non-metabolic examples until it is automatic.

§12.10 (eating disorders). Some students in any room of reasonable size have a personal history here. Three rules:

  • Teach it clinically. No before-and-after imagery, no worked descriptions of restrictive behavior, no self-assessment instrument. The section deliberately contains no checklist and none should be added.
  • Do not solicit personal disclosure, and redirect it gently if offered. The line to hold is that detection is a clinician's assessment, not a self-assessment — including for people in this room.
  • Signpost help at the start rather than the end of the session, and point at Appendix M. Note that contact details change and should be verified.

Also worth stating out loud: eating disorders occur at every body size and are diagnosed later in larger bodies. Students in larger bodies have frequently been congratulated for behavior that would have triggered concern in someone smaller, and naming that structural failure is more useful than any warning sign list.

Throughout: no moral grading. Watch for it in your own framing as much as theirs. Phrases like "taking the easy way," "should be able to do it themselves," and "at least they're trying" all encode a position the chapter refuses. So does the opposite framing that treats any behavioral account as bigotry.


Where students will push back, and what to do

  • "Why won't the book just say obesity is a disease?" Because that is a contested classification with interested parties on both sides and the book's promise is fair presentation. Redirect to what the book does commit to: the physiology, the chronic-therapy framing, and the logical point about levers.
  • "Isn't the compounding stuff just corporations protecting profits?" Partly. Also: the 2013 law creating the 503A/503B framework was passed after contaminated compounded injections killed people. Both facts are true and students should hold both.
  • "So we should just cover it for everyone." Ask them to name what gets cut, or by how much premiums rise and who pays them. Case study 2 exists for this conversation. The point is not that coverage is wrong; it is that "just cover it" is not yet an argument.
  • "The harm in §12.8 is speculative." Correct, and the chapter says so three times. Turn it into the productive question: what study would settle it, and why has nobody run it?

Assessment suggestions

  • Best single written assessment: exercise 12.31 (four positions, then a labelled personal view). Grade the separation, not the conclusion.
  • Best short assessment: exercise 12.12 (rewrite the SELECT headline in 25 words). Fast to mark, and it exposes whether relative-versus-absolute has actually landed.
  • Best group work: case study 2, discussion question 4 — design a coverage policy under a fixed budget, then state who is excluded and what happens to them. Groups reliably do the first half and skip the second; the second half is the assessment.
  • Quiz as written is suitable for a low-stakes pre-session check. Items 3–8 are pure recall of the supplied figures; items 18–22 are the conceptual ones and are where discussion should start.